Predominance ofLactobacillusspp. Among Patients Who Do Not Acquire Multidrug-Resistant Organisms | Zendy

Rafael Araos | Zendy; Albert Tai | Zendy; Graham M. Snyder | Zendy; Martin J. Blaser | Zendy; Erika M. C. D’Agata | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Predominance ofLactobacillusspp. Among Patients Who Do Not Acquire Multidrug-Resistant Organisms

Author(s) -

Rafael Araos,

Albert Tai,

Graham M. Snyder,

Martin J. Blaser,

Erika M. C. D’Agata

Publication year - 2016

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciw426

Subject(s) - medicine , enterococcus , antimicrobial , feces , microbiome , lactobacillus , multiple drug resistance , human microbiome , infection control , microbiology and biotechnology , intensive care medicine , drug resistance , biology , antibiotics , bacteria , bioinformatics , disease , genetics

The emergence and dissemination of multidrug-resistant organisms (MDROs) is a global threat. Characterizing the human microbiome among hospitalized patients and identifying unique microbial signatures among those patients who acquire MDROs may identify novel infection prevention strategies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research